Status:
UNKNOWN
LACTACOL 01 - Impact of Breast Milk on the Neurodevelopment of Preterm Newborns
Lead Sponsor:
Nantes University Hospital
Conditions:
Prematurity of Fetus
Eligibility:
All Genders
28-34 years
Brief Summary
The aim of the study is to estimate the impact of the protein content of breastmilk at the end of hospitalization of the preterm newborn, on the neurodevelopment at 2 years old. The investigators exp...
Eligibility Criteria
Inclusion
- Maternal decision of breastfeeding
- Born between 28 and 34 weeks of amenorrhea
- No important congenital pathology except prematurity
- Efficiency of the breastfeeding compatible with the research by the investigator
- Information and authorization of the parents or the parental authority
Exclusion
- Maternal decision of not breastfeeding
- Born before 28 weeks of amenorrhoea or after or at 34 weeks of amenorrhoea
- Important congenital pathology
- Efficiency of the breastfeeding incompatible with the research by the investigator
- Opposition from parents or the parental authority to participate to the research study
Key Trial Info
Start Date :
October 25 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01493063
Start Date
October 25 2011
End Date
September 1 2025
Last Update
May 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Nantes
Nantes, France